Privacy Policy

Listen to the Burg Simpson Fighters for Justice talk about:
Personal Injury
Dangerous Drugs
Other Topics
Join Our Mailing List
Email:

Home > Dangerous Drugs > Reglan

Reglan Attorneys

In Colorado, Wyoming, Ohio and Nationwide

The lawyers at Burg Simpson Eldredge Hersh & Jardine, PC are currently evaluating cases on behalf of those injured by Reglan. Reglan (generically known as metoclopramide) is a prescription drug used to treat a number of gastrointestinal conditions including gastroesophageal reflux (GERD, Heartburn; Acid Reflux Disease). Reglan is a dopamine antagonist that increases lower esophageal sphincter pressure and improves gastrointestinal emptying. The FDA approved Reglan, which is manufactured by Baxter Healthcare Corp., for short-term (four to twelve weeks) use and only after other more conservative methods of treatment have failed. While the FDA has approved Reglan only for short-term use, approximately 1/3 of patients are being prescribed the medication for 12 months or greater.

Tardive Dyskinesia

Reglan has been linked with serious side effects including tardive dyskinesia, a neurological disorder which causes involuntary movements of the tongue, mouth, face, lips and sometimes arms, trunk or legs. Tardive dyskinesia can be caused by the long-term use of neuroleptic drugs. Reglan also has neuroleptic characteristics. Tardive dyskinesia is most often characterized by repetitive, involuntary, purposeless movements.

Patients suffering from tardive dyskinesia may exhibit involuntary facial gestures, such as grimacing, tongue protrusion, lip smacking, puckering and pursing, and rapid eye blinking. They may also suffer rapid and involuntary movements of the fingers, hands, arms, shoulders, legs, and trunk. Tardive dyskinesia can even adversely affect the ability to breathe, swallow, walk, and talk. The warning label for Reglan mentions tardive dyskinesia, but fails to disclose the true frequency in which it occurs in Reglan users. Two studies have determined the prevalence of Tardive Dyskinesia to be between 27 percent and 29 percent in long-term users.

Neuroleptic Malignant Syndrome

Reglan has also been linked to neuroleptic malignant syndrome (also known as NMS). Neuroleptic malignant syndrome is normally associated with antipsychotic drugs. It is an extremely serious syndrome that usually creates a neurological emergency and can result in death. Most patients develop neuroleptic malignant syndrome shortly after initial exposure to a drug.

Neuroleptic malignant syndrome symptoms include high fever, sweating, unstable blood pressure, stupor, muscular rigidity, and autonomic dysfunction. In most cases, the disorder develops within the first two weeks of treatment with the drug; however, the disorder may develop any time during the therapy period.

Recently, the FDA issued an advisory that required the manufacturer of Reglan to update the product’s label. The advisory calls for a “black box” warning – the strongest warning that the FDA can issue.

If you or a loved one has taken Reglan and has experienced any of these symptoms or has been diagnosed with tardive dyskinesia or neuroleptic malignant syndrome contact the attorneys at Burg Simpson Eldredge Hersh & Jardine, PC for a free evaluation of your potential claims against Baxter.

Return to the Dangerous Drugs Section

Contact Us
1-888-895-2080

Colorado Wyoming Ohio Arizona

 

 

 

Burg Simpson Eldredge Hersh & Jardine, P.C. is a law firm serving the Rocky Mountain Region. The firm has offices in Denver, Colorado, Cody, WY, Cincinnati, Ohio, & Phoenix, AZ. The Firm is responsible for the content on the website,this information is not to be interpreted as providing legal services,
nor as proposing any form of legal advice.